Canopy 2016 A_R_Pages_web
You also want an ePaper? Increase the reach of your titles
YUMPU automatically turns print PDFs into web optimized ePapers that Google loves.
34 |<br />
CGC Annual Review : <strong>2016</strong> | 35<br />
07.<br />
International<br />
In recent years, the actions of many<br />
governments around the world have<br />
signaled a significant change in attitudes<br />
towards the legalization of marijuana.<br />
At the recent UN General Assembly Special Session on Drugs<br />
(UNGASS), the Government of Canada took centre stage<br />
by announcing its intention to introduce, by the spring of<br />
2017, legislation legalizing recreational marijuana use. Many<br />
countries are pushing for drug consumption to be seen in a<br />
different light, one that moves beyond prohibition to one that<br />
emphasizes public health and education and defunding criminal<br />
organizations around the world.<br />
With changing global attitudes towards marijuana, many<br />
countries are looking to Canada, and its regulatory framework<br />
that is driving the commercialization of medical<br />
marijuana, with much respect. As jurisdictions move towards<br />
establishing new or improved medical marijuana systems,<br />
they are looking to companies acting within the Canadian<br />
framework for expertise, knowledge, financial strength and<br />
potentially product to share. Having established and now<br />
expanding our dominant position in the Canadian medical<br />
marijuana market, third parties in countries around the<br />
world want to work with <strong>Canopy</strong> Growth and its subsidiaries.<br />
We believe a significant opportunity exists currently and<br />
will develop further in the future, to leverage our expertise,<br />
financial strength and business model in developing legal<br />
marijuana markets around the world. To date <strong>Canopy</strong> Growth<br />
has established three international partnerships including an<br />
ownership position in AusCann Holdings of Australia, a joint<br />
venture, Bedrocan Brazil, and an export arrangement in place<br />
with a partner in Germany. Other exciting opportunities<br />
exist and, in time, we will expand <strong>Canopy</strong> into other markets.<br />
The international business opportunities being pursued by<br />
<strong>Canopy</strong> Growth include providing advisory services to third<br />
parties, exporting medical cannabis and, of most interest, the<br />
ownership of cannabis cultivation and sales operations in<br />
countries outside of Canada.